Annual CFO
-$17.30 M
-$39.76 M-177.04%
31 December 2023
Summary:
Pharming Group NV annual cash flow from operations is currently -$17.30 million, with the most recent change of -$39.76 million (-177.04%) on 31 December 2023. During the last 3 years, it has fallen by -$100.93 million (-120.69%). PHAR annual CFO is now -120.69% below its all-time high of $83.63 million, reached on 31 December 2020.PHAR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$9.74 M
+$22.96 M+173.69%
30 September 2024
Summary:
Pharming Group NV quarterly cash flow from operations is currently $9.74 million, with the most recent change of +$22.96 million (+173.69%) on 30 September 2024. Over the past year, it has increased by +$6.21 million (+176.21%). PHAR quarterly CFO is now -71.51% below its all-time high of $34.19 million, reached on 31 December 2017.PHAR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$451.00 K
+$6.21 M+107.82%
30 September 2024
Summary:
Pharming Group NV TTM cash flow from operations is currently $451.00 thousand, with the most recent change of +$6.21 million (+107.82%) on 30 September 2024. Over the past year, it has increased by +$24.09 million (+101.91%). PHAR TTM CFO is now -99.51% below its all-time high of $91.94 million, reached on 30 June 2020.PHAR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -177.0% | +176.2% | +101.9% |
| 3 y3 years | -120.7% | +77.4% | -98.9% |
| 5 y5 years | -137.3% | -59.0% | -99.3% |
PHAR Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -120.7% | at low | -38.9% | +142.8% | -98.9% | +101.9% |
| 5 y | 5 years | -120.7% | at low | -59.4% | +142.8% | -99.5% | +101.9% |
| alltime | all time | -120.7% | +31.9% | -71.5% | +142.8% | -99.5% | +101.3% |
Pharming Group NV Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.74 M(-173.7%) | $451.00 K(-107.8%) |
| June 2024 | - | -$13.22 M(+72.9%) | -$5.76 M(+166.4%) |
| Mar 2024 | - | -$7.65 M(-166.1%) | -$2.16 M(-87.5%) |
| Dec 2023 | -$17.30 M(-177.0%) | $11.58 M(+228.2%) | -$17.30 M(-26.8%) |
| Sept 2023 | - | $3.53 M(-136.7%) | -$23.64 M(+62.4%) |
| June 2023 | - | -$9.62 M(-57.8%) | -$14.55 M(+1455.0%) |
| Mar 2023 | - | -$22.79 M(-535.2%) | -$936.00 K(-104.2%) |
| Dec 2022 | $22.46 M(-40.7%) | $5.24 M(-58.5%) | $22.46 M(-32.3%) |
| Sept 2022 | - | $12.62 M(+215.6%) | $33.16 M(+27.4%) |
| June 2022 | - | $4.00 M(+556.5%) | $26.03 M(-17.1%) |
| Mar 2022 | - | $609.00 K(-96.2%) | $31.39 M(-17.0%) |
| Dec 2021 | $37.84 M(-54.7%) | $15.93 M(+190.2%) | $37.84 M(-6.7%) |
| Sept 2021 | - | $5.49 M(-41.3%) | $40.58 M(-25.3%) |
| June 2021 | - | $9.36 M(+32.5%) | $54.34 M(-21.2%) |
| Mar 2021 | - | $7.06 M(-62.2%) | $68.95 M(-17.6%) |
| Dec 2020 | $83.63 M(+12.8%) | $18.67 M(-3.0%) | $83.63 M(-4.3%) |
| Sept 2020 | - | $19.25 M(-19.7%) | $87.41 M(-4.9%) |
| June 2020 | - | $23.97 M(+10.2%) | $91.94 M(+8.3%) |
| Mar 2020 | - | $21.74 M(-3.2%) | $84.87 M(+14.5%) |
| Dec 2019 | $74.15 M(+60.0%) | $22.45 M(-5.6%) | $74.15 M(+9.4%) |
| Sept 2019 | - | $23.79 M(+40.8%) | $67.79 M(+7.3%) |
| June 2019 | - | $16.89 M(+53.3%) | $63.19 M(+7.9%) |
| Mar 2019 | - | $11.02 M(-31.5%) | $58.54 M(+26.3%) |
| Dec 2018 | $46.34 M(+1.1%) | $16.10 M(-16.1%) | $46.34 M(-28.1%) |
| Sept 2018 | - | $19.18 M(+56.6%) | $64.43 M(+4.4%) |
| June 2018 | - | $12.24 M(-1133.5%) | $61.70 M(+23.6%) |
| Mar 2018 | - | -$1.18 M(-103.5%) | $49.92 M(+8.9%) |
| Dec 2017 | $45.84 M | $34.19 M(+107.9%) | $45.84 M(+213.7%) |
| Sept 2017 | - | $16.45 M(+3384.2%) | $14.61 M(-353.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $472.00 K(-109.0%) | -$5.76 M(-53.8%) |
| Mar 2017 | - | -$5.27 M(-277.8%) | -$12.46 M(+18.4%) |
| Dec 2016 | -$10.52 M(-43.7%) | $2.96 M(-175.4%) | -$10.52 M(-38.1%) |
| Sept 2016 | - | -$3.93 M(-36.9%) | -$17.01 M(-4.4%) |
| June 2016 | - | -$6.23 M(+87.1%) | -$17.80 M(+3.5%) |
| Mar 2016 | - | -$3.33 M(-5.6%) | -$17.20 M(-8.0%) |
| Dec 2015 | -$18.70 M(+497.5%) | -$3.53 M(-25.2%) | -$18.70 M(+1904.2%) |
| Sept 2015 | - | -$4.71 M(-16.2%) | -$932.80 K(-164.9%) |
| June 2015 | - | -$5.63 M(+16.6%) | $1.44 M(-185.4%) |
| Mar 2015 | - | -$4.83 M(-133.9%) | -$1.68 M(-46.2%) |
| Dec 2014 | -$3.13 M(-77.0%) | $14.23 M(-707.6%) | -$3.13 M(-59.7%) |
| Sept 2014 | - | -$2.34 M(-73.2%) | -$7.76 M(+45.9%) |
| June 2014 | - | -$8.75 M(+39.5%) | -$5.32 M(+94.7%) |
| Mar 2014 | - | -$6.27 M(-165.3%) | -$2.73 M(<-9900.0%) |
| Dec 2013 | - | $9.60 M(+9696.9%) | $0.00(-100.0%) |
| Sept 2013 | - | $98.00 K(-101.6%) | -$8.23 M(-36.3%) |
| June 2013 | - | -$6.16 M(+74.0%) | -$12.92 M(+3.4%) |
| Mar 2013 | - | -$3.54 M(-357.4%) | -$12.49 M(-8.0%) |
| Dec 2012 | -$13.58 M(-38.1%) | $1.38 M(-129.9%) | -$13.58 M(-59.6%) |
| Sept 2012 | - | -$4.60 M(-19.9%) | -$33.62 M(+4.1%) |
| June 2012 | - | -$5.73 M(+23.9%) | -$32.31 M(+21.6%) |
| Mar 2012 | - | -$4.63 M(-75.2%) | -$26.57 M(+21.1%) |
| Dec 2011 | -$21.94 M(-13.7%) | -$18.66 M(+468.2%) | -$21.94 M(+568.2%) |
| Sept 2011 | - | -$3.28 M(-117.4%) | -$3.28 M(<-9900.0%) |
| Sept 2009 | - | $18.84 M(-280.9%) | $0.00(-100.0%) |
| June 2009 | - | -$10.41 M(+23.5%) | -$18.84 M(+123.5%) |
| Mar 2009 | - | -$8.43 M | -$8.43 M |
| Dec 2006 | -$25.42 M(+66.6%) | - | - |
| Dec 2005 | -$15.26 M | - | - |
FAQ
- What is Pharming Group NV annual cash flow from operations?
- What is the all time high annual CFO for Pharming Group NV?
- What is Pharming Group NV annual CFO year-on-year change?
- What is Pharming Group NV quarterly cash flow from operations?
- What is the all time high quarterly CFO for Pharming Group NV?
- What is Pharming Group NV quarterly CFO year-on-year change?
- What is Pharming Group NV TTM cash flow from operations?
- What is the all time high TTM CFO for Pharming Group NV?
- What is Pharming Group NV TTM CFO year-on-year change?
What is Pharming Group NV annual cash flow from operations?
The current annual CFO of PHAR is -$17.30 M
What is the all time high annual CFO for Pharming Group NV?
Pharming Group NV all-time high annual cash flow from operations is $83.63 M
What is Pharming Group NV annual CFO year-on-year change?
Over the past year, PHAR annual cash flow from operations has changed by -$39.76 M (-177.04%)
What is Pharming Group NV quarterly cash flow from operations?
The current quarterly CFO of PHAR is $9.74 M
What is the all time high quarterly CFO for Pharming Group NV?
Pharming Group NV all-time high quarterly cash flow from operations is $34.19 M
What is Pharming Group NV quarterly CFO year-on-year change?
Over the past year, PHAR quarterly cash flow from operations has changed by +$6.21 M (+176.21%)
What is Pharming Group NV TTM cash flow from operations?
The current TTM CFO of PHAR is $451.00 K
What is the all time high TTM CFO for Pharming Group NV?
Pharming Group NV all-time high TTM cash flow from operations is $91.94 M
What is Pharming Group NV TTM CFO year-on-year change?
Over the past year, PHAR TTM cash flow from operations has changed by +$24.09 M (+101.91%)